Genmab — April 2018

[E_L]

if we had been trading around this level just before Tuesday, we would have easily been trading above 1300 in my opinion; bears did their work quietly in the first 2 weeks of the month...

[Bulder]

Kan se at de i dag hverken har bud- eller udbudspriser. De plejer at have bud, men ikke udbud.

[Raffles]

Det er budprisen jeg mangler, men som Helge skriver er det nok et hængeparti fra i går.

[E_L]

Novartis expects completion Arzerra iNHL trial to complete Q2-2018 with a publication Q4 https://clinicaltrials.gov/ct2/show/NCT01077518 p64
https://clinicaltrials.gov/ct2/show/NCT01077518

[E_L]

https://www.novartis.com/sites/www.novartis.com/files/q1-2018-ir-presentation.pdf presentation link again p64

[E_L]

OMB157 p60, trials & filings p25, 26

[Helge_LarsenPI-redaktør]

Udbudspriser har ikke været stillet i længere tid.

[E_L]

https://www.dagensmedicin.se/artiklar/2018/04/19/avtal-om-efterlangtat-myelomlakemedel/ Sweden

[rex_pacis]

langt fremskreden...

[Bulder]

Who have we left now in mono? Holland?

[rex_pacis]

I used to be UK, Sweden and Holland; and now UK and Sweden are buying, so I guess Holland will be the last

[E_L]

Sweden is still only mono if i read this correct?

[Bulder]

yes, mono only - same same as UK

[Bulder]

Denmark is on its way. Mono is ok and they have made a draft for 2. line combo. Wil assumably be soc soon. http://www.medicinraadet.dk/media/5467/indstilling-10-behandlingsvejledning-knoglemarvskraeft-myelomatose.pdf

[Bulder]

Here is the draft protocol page 8 http://www.medicinraadet.dk/media/6275/protokol-10-knoglemarvskraeft.pdf

[bibob]

Seems like we are holding in strong hands. But watch, !! - when they release the short positions the bullit is going much stronger and faster than you can buy it for now. - maybe it still falls a bit , But there is no more downside as I see it. Good luck.

[henrik48]

Vi er alle enige med dig, bibob....i dag har vi “Malaga”-vejr

[GeorgeBest]

Ny duobody i klinikken. På side 13 i vedlagte slideshow fra GF anføres JNJ-64407564. Den har ikke tidligere været nævnt! http://files.shareholder.com/downloads/AMDA-KPIBN/138540251x7895654x976323/FA28BE7E-0E02-4A37-8E24-39ACD8F23226/AGM_2018_vfinal_website.pdf

[GeorgeBest]

JNJ-64407564 fra CT https://clinicaltrials.gov/ct2/results?cond=JNJ-64407564&term=&type=&rslt=&age_v=&gndr=&intr=&titles=&outc=&spons=&lead=&id=&cntry=&state=&city=&dist=&locn=&strd_s=&strd_e=&prcd_s=&prcd_e=&sfpd_s=&sfpd_e=&lupd_s=&lupd_e=

[GeorgeBest]

Den må give en lille milepæl når første patienter doseres